Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    New press releases and corporate updates have been added to the Lilly press releases page, including Omvoh UC disease clearance data, a Q1 2026 financial update, a second-quarter dividend declaration, and several acquisitions. Older items, such as Foundayo pricing details and Centessa acquisition content, have been removed.
    Difference
    8%
    Check dated 2026-05-06T12:05:25.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    New addition: Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera, including AJ1-11095 details. Deletion: removal of the press release detailing Taltz plus Zepbound efficacy in psoriatic arthritis and obesity.
    Difference
    2%
    Check dated 2026-04-29T09:24:59.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    New press releases have been added to the listing, including Lilly’s planned acquisition of Kelonia Therapeutics, additional details on Kelonia’s early CAR‑T program, and a saved financial results announcement date. Also added are entries for recent clinical-study updates involving Foundayo (orforglipron), while older press-release items related to EBGLYSS, retatrutide, and Zepbound KwikPen access appear removed from the current visible list.
    Difference
    8%
    Check dated 2026-04-22T05:00:34.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    New press releases about Jaypirca trial results and Foundayo availability with pricing were added, while older items and warnings were removed from the page.
    Difference
    8%
    Check dated 2026-04-15T02:04:09.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added FDA approval press release for Foundayo (orforglipron) with pricing and home-delivery details. Removed Lilly Employer Connect platform pricing content and the CHMP update for Olumiant.
    Difference
    8%
    Check dated 2026-04-07T21:15:55.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    New press releases have been added, including Lilly to acquire Centessa Pharmaceuticals and recent trial results (Taltz+Zepbound and EBGLYSS). Older releases (e.g., the orforglipron Lancet study) have been removed.
    Difference
    8%
    Check dated 2026-03-31T16:40:24.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.